Common questions about Nycoplus Calcigran (FAQ)
Q: Is Nycoplus Calcigran the same as Calcigran Forte?
Official product information describes Nycoplus Calcigran and Calcigran Forte as separate preparations that both contain the active ingredients calcium carbonate and cholecalciferol (Vitamin D3). While they share the same components, preparations with different names may vary in strength, specific formulation details, or local regulatory approval status.
Q: Can Nycoplus Calcigran cause constipation?
Official documentation for this type of combination medicine lists effects on the digestive system as potential adverse reactions. This includes constipation, which is often classified as rare in official sources, meaning it affects a very small number of users.
Q: Does Nycoplus Calcigran interact with thyroid medication?
Regulatory information indicates that Nycoplus Calcigran is documented to interact with thyroid medications like Levothyroxine. Regulatory documents describe a required separation of several hours between the intake of this product and thyroid medicine to prevent reduced systemic exposure of the thyroid medicine.
Q: What is the role of calcium and vitamin D in this medicine?
The combination works together: the calcium component provides structural material for bone, and the Vitamin D component is necessary to help the body absorb that calcium effectively. This action supports the body's mineral homeostasis and bone structural integrity.
Q: Is Nycoplus Calcigran suitable for people with lactose intolerance?
The official documentation lists specific excipients (inactive ingredients) in the formulation, which can include certain sugars or sugar alcohols such as isomalt or sucrose. If there are known sensitivities to lactose or specific excipients, official product information contains the full list of ingredients for review.
Q: Is there any research that supports the use of Nycoplus Calcigran?
Studies on the combination of calcium and Vitamin D3 support its use for bone health. Research indicates that this type of supplementation may be associated with a reduced risk of total and hip fractures, especially in individuals with existing Vitamin D deficiency or those at high risk of osteoporosis.
Q: Why is the calcium carbonate form used in Nycoplus Calcigran?
Regulatory documents identify the salt as Calcium Carbonate. This form is described as a bioavailable source of supplemental calcium often utilized in clinical settings. The active ingredients are supplied in this form to support the product's intended action.
Q: What is the difference in effect between a chewable tablet and a regular pill?
The regulatory documents require the tablet to be chewed or sucked and not swallowed whole. This method of administration is specific to the chewable tablet formulation and supports the proper dissolution of ingredients, which is essential for the medicine's function.
Q: Can I crush or split the Nycoplus Calcigran tablets?
The official instruction for this medicine specifies that the tablet must be consumed by chewing or sucking it, not swallowing it whole. The method of ingestion is defined by the product's design, as described in the official administration documents.
Q: Does taking Nycoplus Calcigran at a certain time of day matter?
Official instructions specify taking the medicine twice daily, but state that it generally can be taken independent of meals. The timing of intake may be adjusted to avoid interactions with certain co-administered medications, as described in the official documentation.
Q: Is Nycoplus Calcigran a prescription medicine or over-the-counter?
Nycoplus Calcigran is often classified in regulatory documents as a non-prescription product, meaning it is available over-the-counter. Its primary use is for treating or preventing states of calcium and Vitamin D deficiency.
Q: Are there any known interactions between Nycoplus Calcigran and coffee or tea?
Official documents note that specific substances in certain foods, such as oxalic or phytic acid, may reduce calcium absorption. While coffee or tea are not explicitly named in regulatory warnings, the general concern relates to substances that can inhibit mineral absorption.
Q: Who is generally considered eligible to use Nycoplus Calcigran?
The product is officially designated for use in Adults and Older Adults. It is used to address established deficiencies in calcium and Vitamin D or as an additional treatment for conditions like osteoporosis.
Q: Is Nycoplus Calcigran appropriate for children?
Official regulatory documents state that the medicine is not intended or not recommended for use in Children and Adolescents under 18 years of age. This restriction is primarily due to the fixed, high dose of Vitamin D contained in the formulation.
Q: Does Nycoplus Calcigran contain sugar or sweeteners?
Official documents list excipients such as sucrose, isomalt, or sorbitol (sweeteners) in the formulation. This information is required for consumers who monitor sugar intake.
Q: What are the signs of taking too much Nycoplus Calcigran?
Symptoms of taking too much are primarily linked to hypercalcaemia, which is an elevated level of calcium in the blood. Signs may include gastrointestinal symptoms like nausea, vomiting, or constipation, as well as increased thirst or increased urination.
Q: Is there a risk of interaction with heart medications?
Official information indicates that co-administration with certain heart medications called cardiac glycosides may increase the risk of toxicity. Therefore, the regulatory label specifies that use with these types of medicines requires close monitoring.
Q: Do studies show Nycoplus Calcigran helps with fracture prevention?
Research involving the combination of calcium and cholecalciferol indicates that supplementation may be associated with a reduced risk of total fractures, including hip fractures. This effect is most often seen in specific populations, such as those with pre-existing Vitamin D deficiency.
Q: What is the significance of the strength of Nycoplus Calcigran?
The strength (e.g., 500mg/400 IU) represents the fixed amount of elemental calcium and Vitamin D3 contained in each tablet. This specific, standardized ratio is set to treat or prevent documented deficiencies as defined by the regulatory approval.
Q: Is Nycoplus Calcigran meant to be a permanent treatment?
Regulatory documents describe the product’s use for treating or preventing deficiency states and as adjunct therapy. Long-term use is associated with monitoring requirements due to the potential risk of hypercalcaemia, as outlined in the official warnings.
Q: Is it safe to use Nycoplus Calcigran long-term?
For prolonged treatment, the regulatory label specifies that patient monitoring is necessary. Specifically, blood calcium levels and kidney function (measured by serum creatinine) must be checked, especially in patients who may be at risk of developing high calcium levels.
Q: Does Nycoplus Calcigran cause fatigue or dizziness?
Neither fatigue nor dizziness is listed as a primary or common side effect in official safety documentation. However, these symptoms may be associated with severe cases of hypercalcaemia (elevated calcium in the blood), which is a potential adverse effect of the medicine.
